When a university or research institution licenses a patent and starts collecting royalty payments, two separate tax questions come up that are easy to conflate: is the royalty income taxable to the institution, and is the inventor’s share of that income taxable to the inventor? This guide covers both at a principle level, for a U.S. nonprofit research institution’s technology transfer office (TTO), finance office, or research administrator who needs to understand the shape of the issue well enough to route it to tax counsel — not to replace that counsel. Specific rates, thresholds, and IRS positions change over time and vary by jurisdiction; nothing here should be read as tax advice for a specific transaction. This page is deliberately distinct from CASRAI’s royalty rate-setting guide, which covers how a TTO arrives at the royalty percentage or fee structure in the first place — the methodology question. This page covers what happens to that money, tax-wise, once it’s collected.
Two Separate Questions, Two Separate Bodies of Law
Royalty income in a university tech-transfer context touches at least two distinct tax regimes:
- The institution’s own tax-exempt status — whether the royalty income the university itself collects counts as taxable Unrelated Business Income (UBI), governed by Internal Revenue Code Section 512.
- The inventor’s personal income tax — whether the inventor’s statutorily-required share of that royalty income, once distributed to them individually, is ordinary taxable income, and if so, how it’s characterized.
These are independent questions. An institution’s royalty income can be cleanly excluded from UBIT while the individual inventor’s share is still fully taxable to that inventor as personal income — in fact, that’s the typical outcome, not an edge case.
Is Royalty Income Taxable to the University? The UBIT Royalty Exclusion
Most U.S. research universities and affiliated foundations hold federal tax-exempt status under IRC Section 501(c)(3). Income from a trade or business regularly carried on that isn’t substantially related to the organization’s exempt educational or research mission is generally subject to Unrelated Business Income Tax (UBIT) under Section 511. Licensing royalties, however, get specific favorable treatment: IRC Section 512(b)(2) excludes “all royalties” — along with deductions directly connected to that income — from the UBI calculation, regardless of whether the underlying activity would otherwise look like an unrelated trade or business.
The practical condition the IRS applies, developed through a long line of exempt-organization guidance and case law rather than a single bright-line statutory test, is that the exempt organization’s role in generating the income has to be passive. A university that licenses a patent and collects a percentage of the licensee’s net sales — without providing ongoing services, without an active role running the licensed business, and without the payment really being compensation for personal services — is squarely within the royalty exclusion. Where an institution’s involvement becomes active (for example, bundling licensing with substantial services, technical support, or co-marketing that goes beyond simply granting the right to use the IP), the IRS can recharacterize some or all of the payment as something other than a royalty, pulling it back into UBIT exposure. The term “royalty” itself isn’t statutorily defined; the IRS and courts determine it case by case based on the facts of the arrangement, not the label the license agreement uses.
Two related wrinkles TTOs should know exist, without needing to resolve them unassisted:
- Debt-financed property (IRC Section 514). If the underlying patent or the research that produced it was financed with debt the institution hasn’t fully paid off, royalty income can lose part of the Section 512(b)(2) exclusion under the unrelated debt-financed income rules — a separate, narrower carve-back from the general royalty exclusion.
- Active vs. passive licensing arrangements. Sponsored-research agreements, cost-sharing arrangements, and licenses that bundle IP rights with ongoing services (a common structure in university-startup deals) sit closer to the line than a simple arm’s-length license to an established company — exactly the kind of fact pattern that benefits from institutional tax counsel review before signing, not after.
For most straightforward university patent licenses — a license granting rights to make/use/sell in exchange for royalty payments, with no substantial ongoing services bundled in — the Section 512(b)(2) exclusion is the default, well-established outcome. See the IRS’s own exempt-organizations guidance on royalty income (Exempt Organizations Continuing Professional Education Technical Instruction Program, “Royalties”) for the fuller facts-and-circumstances discussion.
Bayh-Dole’s Inventor-Share Requirement
For inventions arising from federally funded research where the institution elected title under the Bayh-Dole Act, the statute itself dictates part of what happens to royalty income before any tax question arises. Under 35 U.S.C. § 202(c)(7)(B), a nonprofit institution’s funding agreement with the government must require that the institution share royalties with the inventor. Bayh-Dole doesn’t set the percentage — that’s left to each institution’s own intellectual property policy, and shares (and how they’re tiered as cumulative royalties grow) vary meaningfully across institutions. Section 202(c)(7)(C) further requires that whatever royalty income remains after paying the inventor’s share and the costs of administering the patent (filing, prosecution, maintenance) be used by the institution for scientific research or education — a use-of-proceeds constraint tied to the institution’s tax-exempt purpose, reinforcing why the UBIT exclusion above matters: money that has to be reinvested in the exempt mission is exactly the kind of income Section 512(b)(2) is meant to leave outside the unrelated-business tax base.
Is the Inventor’s Royalty Share Taxable Income?
Once the institution distributes the inventor’s contractually or statutorily required share, that payment is income to the inventor as an individual — this part is not in serious dispute. The harder, genuinely jurisdiction- and fact-specific question is how that income is characterized:
- Ordinary income is the default and most common treatment. Because the inventor is typically a university employee, and the payment flows from the university’s own licensing revenue under the institution’s IP policy rather than from the inventor personally selling or assigning patent rights in an arm’s-length transaction, most institutional royalty-share distributions to faculty/staff inventors are treated and reported as ordinary taxable income (in the U.S., generally by information return, commonly Form 1099), not as capital gain.
- Capital gains treatment is a narrower, separate question that mainly arises for individual inventors selling or exclusively licensing patent rights directly, not for institutional royalty-share distributions. IRC Section 1235 allows certain individual inventors (or their statutory successors) who transfer substantially all rights in a patent to treat the resulting payments as long-term capital gain regardless of holding period. Whether and how this interacts with a university employee’s Bayh-Dole royalty share — where the university, not the individual inventor, holds title and does the licensing — is a fact-specific question that depends on the institution’s IP assignment agreement and the inventor’s actual legal position, and is squarely a question for tax counsel on the specific facts, not something to assume either way from general principles.
Because inventor tax treatment depends on individual facts (employment status, assignment terms, whether any portion of the share could be argued to relate to a personal sale of rights rather than an employer distribution) and on tax law that changes over time, TTOs and research administrators should route inventor questions about their own royalty-share tax treatment to the institution’s tax or payroll office rather than answering them directly — this is exactly the kind of individualized advice a general reference page cannot responsibly give.
Why This Is a Different Question From Royalty Rate-Setting
It’s worth being explicit about the boundary with CASRAI’s companion guide on royalty rate setting, since the two topics get conflated. Rate-setting is a valuation and negotiation question: what percentage or fee structure reflects the technology’s value, using tools like the (now largely discredited) 25% rule, comparables, or the Georgia-Pacific factors. Taxation is a downstream question that only starts once money is actually flowing: given that a royalty stream now exists at whatever rate was negotiated, how is that income treated under tax law, both for the institution collecting it and the inventor receiving a share of it. An institution can get the rate-setting methodology exactly right and still create an unnecessary UBIT or inventor-withholding problem through how the license or the internal distribution is structured — the two workstreams need to talk to each other, but they’re not the same analysis.
International Considerations, Briefly
Institutions and inventors outside the United States, or U.S. institutions licensing to foreign entities, face a materially different picture: non-U.S. jurisdictions have their own charity/nonprofit tax exemption frameworks (which may or may not include an equivalent to the UBIT royalty exclusion), cross-border royalty payments can trigger withholding tax subject to applicable tax treaties, and VAT/GST treatment of licensing transactions varies by country. None of the U.S.-specific analysis above should be assumed to transfer directly to a non-U.S. institution or a cross-border license — that requires jurisdiction-specific tax and treaty analysis.
Frequently Asked Questions
Does a university have to pay tax on patent royalty income?
Generally no, under the IRC Section 512(b)(2) royalty exclusion from Unrelated Business Income Tax, provided the institution’s role in the licensing arrangement is passive and the payment genuinely qualifies as a royalty rather than compensation for services. Debt-financed property and heavily service-bundled licenses are the main exceptions worth flagging to tax counsel.
Is an inventor’s share of royalty income taxable?
Yes — the inventor’s distributed share is taxable income to the inventor. It is typically treated as ordinary income rather than capital gain when it’s a distribution from the university’s own licensing revenue under institutional IP policy, though the precise characterization depends on individual facts and is a question for the institution’s tax office, not a general reference page.
Does Bayh-Dole require universities to share royalties with inventors?
Yes. 35 U.S.C. § 202(c)(7)(B) requires that a nonprofit institution’s funding agreement include a requirement to share royalties with the inventor on federally funded inventions where the institution elected title. The statute does not set the percentage; that’s determined by each institution’s own IP policy.
What happens to royalty income after the inventor’s share is paid?
Under 35 U.S.C. § 202(c)(7)(C), the remainder — after the inventor’s share and the costs of patent administration — must be used by the institution for scientific research or education, consistent with its tax-exempt purpose.
Is this guide tax advice?
No. This page explains the general shape of the issue so research administrators can recognize it and route it appropriately. Specific determinations depend on individual facts, current IRS guidance, and (outside the U.S.) local tax law, and should go through institutional tax counsel or the sponsored-programs/tax office.
